NCT07383051 A Randomized Clinical Trial for Predictors of Successful Extubation of Pediatric Patients With or Without High Velocity Nasal Insufflation
| NCT ID | NCT07383051 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | High Velocity Nasal Insufflation |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-09-20 |
| Primary Completion | 2027-03-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-09-20 with a primary completion date of 2027-03-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A randomized clinical trial about predictors of successful extubation of pediatric patients from mechanical ventilation either on High Velocity Nasal Insufflation or simple nasal oxygen and comparing the outcome
Eligibility Criteria
Inclusion Criteria: * Age between 2 months and 13 years old with minimum weight 4kg * Both sexes * Patients on mechanical ventilation for at least 24 hours for any indication Exclusion Criteria: * Patients not ready for weaning from mechanical ventilation * Contraindications to use of High velocity nasal insufflation * Prolonged mechanical ventilation for more than 21 days
Contact & Investigator
Cairo University Cairo University
PRINCIPAL INVESTIGATOR
Cairo University
Frequently Asked Questions
Who can join the NCT07383051 clinical trial?
This trial is open to participants of all sexes, aged 2 Months or older, up to 13 Years, studying High Velocity Nasal Insufflation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07383051 currently recruiting?
Yes, NCT07383051 is actively recruiting participants. Contact the research team at tareksherin16@gmail.com for enrollment information.
Where is the NCT07383051 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07383051 clinical trial?
NCT07383051 is sponsored by Cairo University. The principal investigator is Cairo University Cairo University at Cairo University. The trial plans to enroll 100 participants.